Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.

Source:http://linkedlifedata.com/resource/pubmed/id/18664590

Download in:

View as

General Info

PMID
18664590